Charts

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company’s common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The second-quarter 2024 cash dividend will be the 342nd consecutive quarterly dividend paid by Pfizer.

Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?

While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.

Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco. The post The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly. The post 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Alcohol, tobacco, and drugs as bulwarks against market shocks, and these three stocks are now trading under low ballparks.

ModernaInc.(NASDAQ:MRNA)is setto clash withPfizer Inc.(NYSE:PFE) ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth. The post 3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

These two pharma stocks have followed distinct paths of late. Which is the better investment?

This Vanguard growth fund is home to some of the world's most innovative companies.

Pfizer is engaged in the discovery, development, manufacture, marketing, sale, and distribution of biopharmaceutical products worldwide.

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.

Pfizer (PFE) reachead $26.26 at the closing of the latest trading day, reflecting a +1% change compared to its last close.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These are the undervalued blue-chip stocks to buy as they represent fundamentally strong ideas poised for accelerated growth. The post 3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 18 ...

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO® (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options.

In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]

A little up-front investment can go a long way with these three stocks.

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.

Investors in Pfizer Inc (PFE) saw new options become available today, for the December 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

The answer to that question will either make you wince or smile.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media. The post The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

The firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist for Pfizer’s emerging science and innovation unit.

A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.

On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report.Adjusted ...

Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Pfizer Inc (PFE), where a total of 163,469 contracts have traded so far, representing approximately 16.3 million underlying shares. That amounts to about 43.8% of PFE's average daily trading volume over the past month of 37.3 million shares..

Financial giants have made a conspicuous bearish move on Pfizer. Our analysis of options history for Pfizer (NYSE:PFE) revealed 11 ...

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

The pharmaceutical giant is laying the groundwork for its next heyday.

The average yield from these stocks is more than five times the market average.

In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]

These three stocks are bargains with great dividends.

These dividend payers have a long history of steady dividend payout raises, and they both offer yields above 6% at recent prices.

When something seems too good to be true it might not be.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments The post If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2024 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 25, 2024. Pfizer has designed the virtual Annual Meeting to ensure that its shareholders who attend the virtual-only Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies ...

Pfizer (PFE) is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer’s share price fell 36.6% from $41.50 to $26.31 as of Wednesday’s market close.

The global market study pneumococcal conjugate (PCV) market is ~$8 billion per year, andVaxcyte Inc(NASDAQ:PCVX) estimates ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services. It’s one of the essentials of life, which makes the industry such a politically sensitive matter. Besides the critical need, another element that helps bolster… The post 7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Bristol Myers Squibb(NYSE: BMY), Merck& Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE)and Johnson & Johnson(NYSE: ...

In a strategic move to strengthen economic ties, Japanese Prime Minister Fumio Kishida has reached out to American business leaders, ...

Is this top healthcare stock a good buy for the long run?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. The post Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

Tuesday,Pfizer Inc(NYSE:PFE) released top-line immunogenicity and safety data from the ongoing pivotal Phase 3 MONeT ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) ...

We've also got a look at 3M's spinoff, gold prices, and the beef industry.

A rate cut would likely be a boon for these two ultra-high yield dividend stocks.

Pfizer Inc. (NYSE: PFE) today announced positive top-line immunogenicity and safety data from the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT (RSV IMmunizatiON Study for AdulTs at Higher Risk of Severe Illness), evaluating a single dose of ABRYSVO versus placebo in adults 18 to 59 years of age at risk of developing severe respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD).

These companies are close to launching new products that could supercharge revenue.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors. The post 3 Dirt-Cheap Stocks That Could Make You Filthy Rich appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

The current status of this stock might seem bleak. But like a chess grandmaster, Griffin is looking several moves ahead.

These stocks, a bargain today, are players to hold on to for the long term.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results. The post Why Is Ocugen (OCGN) Stock Up 7% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said Amazon.com, Inc. (NASDAQ: AMZN) is on ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the U.S. Food and Drug Administration (FDA) approved Dovato (dolutegravir/lamivudine) for the treatment of HIV-1 infection in adolescents 12 years of age and older and weighing at least 25 kg with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known substitutions associated with resistance to the individual components of Dovato.1

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Health insurers, pharmaceutical companies and medical device manufacturers have all been knocked lower as an aging population drives up medical costs and companies struggle to maintain their profit margins. The post The 3 Most Undervalued Healthcare Stocks to Buy in April 2024 appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.